Inventor · disambiguated record
Andrew Cook
Also filed as: COOK ANDREW · COOK ANDREW S · COOK ANDREW SIMON
21 granted patents·14 pending applications·164 citations·filing 2001–2025
94Inventor score
Files withEISAI R&D MAN CO LTD10CONSTELLATION PHARMACEUTICALS INC8PFIZER7FORUM PHARMACEUTICALS INC3APELLIS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
35 records- 0196US6660756B2N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidasePFIZER·Filed 2002·Granted Dec 9, 2003·92 cites·23 claims
- 0293US9085583B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION—PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·18 cites·14 claims
- 0391US9371331B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2015·Granted Jun 21, 2016·8 cites·9 claims
- 0491US9206128B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2012·Granted Dec 8, 2015·10 cites·17 claims
- 0587US9745305B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Granted Aug 29, 2017·11 cites·17 claims
- 0686US10016405B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted Jul 10, 2018·3 cites·4 claims
- 0786US2025135017A1Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 0885US9980952B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·3 cites·8 claims
- 0984US11352348B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2020·Granted Jun 7, 2022·1 cites·25 claims
- 1083US8916593B2Alkoxy-substituted 2-aminopyridines as ALK inhibitorsBUNNAGE MARK EDWARD·Filed 2011·Granted Dec 23, 2014·8 cites·5 claims
- 1180US7576081B2Morpholine dopamine agonistsPFIZER·Filed 2006·Granted Aug 18, 2009·2 cites·3 claims
- 1277US11945807B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2022·Granted Apr 2, 2024·0 cites·24 claims
- 1377US11679107B2Certain aryl pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Jun 20, 2023·1 cites·19 claims
- 1475US7323462B2Morpholine dopamine agonistsPFIZER·Filed 2003·Granted Jan 29, 2008·5 cites·1 claims
- 1574US2024368140A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 1672US11926619B2Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Mar 12, 2024·1 cites·18 claims
- 1770US12172986B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Dec 24, 2024·0 cites·46 claims
- 1869US7902188B2Morpholine dopamine agonistsPFIZER·Filed 2009·Granted Mar 8, 2011·0 cites·2 claims
- 1967US2025333400A1Certain pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2025·Application pending·0 cites
- 2067US2023301990A1Certain aryl pladienolide compounds and methods of useEISAI R&D MAN CO LTD·Filed 2023·Application pending·0 cites
- 2166US2019125737A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2264US2015376190A1Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2359US6849649B2N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidasePFIZER·Filed 2003·Granted Feb 1, 2005·1 cites·3 claims
- 2457US2024360103A1Complement inhibitionAPELLIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2557US2009005354A1New Amino Derivatives and Their Use as PharmaceuticalsPFIZER·Filed 2008·Application pending·0 cites
- 2649US2005288270A1New aminopyridine derivatives and their use as pharmaceuticalsPFIZER·Filed 2005·Application pending·0 cites
- 2748US2023026271A1Piperazine Compounds for Inhibiting CPS1EISAI R&D MAN CO LTD·Filed 2020·Application pending·0 cites
- 2844US9802927B2Oxadiazine compounds and methods of use thereofDENALI THERAPEUTICS INC·Filed 2016·Granted Oct 31, 2017·0 cites·19 claims
- 2939US10370370B2Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptorsFORUM PHARMACEUTICALS INC·Filed 2016·Granted Aug 6, 2019·0 cites·13 claims
- 3039US2002052370A1Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidaseFiled 2001·Application pending·0 cites
- 3138US10428062B2Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptorsFORUM PHARMACEUTICALS INC·Filed 2016·Granted Oct 1, 2019·0 cites·13 claims
- 3237US2017247393A1Aminoisoxazoline Compounds as Agonists of Alpha7-Nicotinic Acetylcholine ReceptorsFORUM PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3336US2006052435A1Selective dopamin d3 receptor agonists for the treatment of sexual dysfunctionVAN DER GRAAF PIETER H·Filed 2002·Application pending·0 cites
- 3436US2008234254A1Inhibitors of Histone DeacetylaseUNIV LEEDS·Filed 2005·Application pending·0 cites
- 3535US10183938B2Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptorsAXOVANT SCIENCES GMBH·Filed 2015·Granted Jan 22, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Andrew Cook files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →